Beijing Jiliangzheng Smart Medical Technology Co., LTD – Trademark Portfolio
Entity Type: 99
Beijing Jiliangzheng Smart Medical Technology Co., LTD holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SIFUDE. The owner is based in Beijing.
Room 10B, Block A, 10th Floor, No. 28, Jia, Information Road, Haidian District,
Beijing 100000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Beijing Jiliangzheng Smart Medical Technology Co., LTD's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Beijing Jiliangzheng Smart Medical Technology Co., LTD have?
Beijing Jiliangzheng Smart Medical Technology Co., LTD has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.
What trademark classes does Beijing Jiliangzheng Smart Medical Technology Co., LTD file in?
Beijing Jiliangzheng Smart Medical Technology Co., LTD files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Beijing Jiliangzheng Smart Medical Technology Co., LTD's most well-known trademarks?
Beijing Jiliangzheng Smart Medical Technology Co., LTD's registered trademark portfolio includes well-known marks such as SIFUDE. These are among 1 currently registered trademark in the portfolio.
What is Beijing Jiliangzheng Smart Medical Technology Co., LTD's trademark registration success rate?
Beijing Jiliangzheng Smart Medical Technology Co., LTD has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.